Differential Activation of NF-κB, AP-1, and C/EBP in Endotoxin-Tolerant Rats: Mechanisms for In Vivo Regulation of Glomerular RANTES/CCL5 Expression
- 15 June 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 170 (12) , 6280-6291
- https://doi.org/10.4049/jimmunol.170.12.6280
Abstract
Chemokines play a pivotal role in the regulation of inflammatory cell infiltration in glomerular immune injury. To characterize mechanisms relevant for the regulation of chemokine expression in vivo, the LPS-mediated model of renal inflammation in rats was used in which we have previously demonstrated that the chemokine RANTES/CCL5 is expressed and secreted in glomeruli. Glomerular RANTES/CCL5 expression in this model correlated with an increased glomerular binding activity of the transcription factors AP-1, C/EBP, and NF-κB. To gain further insight into the functional roles of these transcription factors in the regulation of glomerular RANTES/CCL5 expression, we cloned the rat RANTES/CCL5 promoter and established the model of in vivo LPS tolerance. In tolerant rats, LPS-induced glomerular RANTES/CCL5 expression and activation of the transcription factors AP-1 and C/EBP were significantly reduced using both consensus and rat RANTES/CCL5-specific oligonucleotides. Reduced glomerular NF-κB binding activity after LPS injection could be demonstrated in tolerant rats only when using rat RANTES/CCL5-specific oligonucleotides. Reduced binding activity to this RANTES/CCL5-specific NF-κB binding site in the context of broad NF-κB activation might be due to changes in transcription factor interactions or chromatin remodeling processes.Keywords
This publication has 58 references indexed in Scilit:
- Chemokines and chemokine receptors are involved in the resolution or progression of renal diseaseKidney International, 2003
- The X-ray Crystal Structure of the NF-κB p50·p65 Heterodimer Bound to the Interferon β-κB SitePublished by Elsevier ,2002
- Surfactant Protein D Gene RegulationJournal of Biological Chemistry, 2002
- Transcription factor-κB (NF-κB) and renal diseaseKidney International, 2001
- Molecular andin silicocharacterization of a promoter module and C/EBP element that mediate LPS‐induced RANTES/CCL5 expression in monocytic cellsThe FASEB Journal, 2001
- Transcription factor decoy for NFκB inhibits TNF-α-induced cytokine and adhesion molecule expression in vivoGene Therapy, 2000
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- Activation of transcription factor NF-κB in experimental glomerulonephritis in ratsPublished by Elsevier ,1999
- Suppression of NF-κB and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: molecular mechanisms of anti-nephritic actionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1997
- Regulation of HIV-1 Long Terminal Repeats by Interaction of C/EBP(NF-IL6) and NF-κB/Rel Transcription FactorsPublished by Elsevier ,1996